Vericel Corp (VCEL)
43.67
-0.19
(-0.43%)
USD |
NASDAQ |
Apr 19, 16:00
43.67
0.00 (0.00%)
After-Hours: 20:00
Vericel Free Cash Flow (Quarterly): 2.251M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.251M |
| September 30, 2023 | 0.60M |
| June 30, 2023 | 6.00M |
| March 31, 2023 | -1.053M |
| December 31, 2022 | 5.85M |
| September 30, 2022 | 2.692M |
| June 30, 2022 | 1.162M |
| March 31, 2022 | 0.387M |
| December 31, 2021 | 9.56M |
| September 30, 2021 | 1.171M |
| June 30, 2021 | 2.651M |
| March 31, 2021 | 7.743M |
| December 31, 2020 | 10.27M |
| September 30, 2020 | 4.20M |
| June 30, 2020 | -3.49M |
| March 31, 2020 | 3.969M |
| December 31, 2019 | 2.789M |
| September 30, 2019 | 6.861M |
| June 30, 2019 | -19.37M |
| March 31, 2019 | -0.078M |
| December 31, 2018 | 2.034M |
| September 30, 2018 | 0.891M |
| June 30, 2018 | -6.236M |
| March 31, 2018 | 0.221M |
| December 31, 2017 | 0.116M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.76M |
| June 30, 2017 | -5.857M |
| March 31, 2017 | -3.192M |
| December 31, 2016 | -9.409M |
| September 30, 2016 | -4.422M |
| June 30, 2016 | -6.194M |
| March 31, 2016 | -1.282M |
| December 31, 2015 | -4.134M |
| September 30, 2015 | -1.493M |
| June 30, 2015 | -5.68M |
| March 31, 2015 | -4.466M |
| December 31, 2014 | -6.991M |
| September 30, 2014 | -8.491M |
| June 30, 2014 | -6.083M |
| March 31, 2014 | -4.674M |
| December 31, 2013 | -4.343M |
| September 30, 2013 | -4.139M |
| June 30, 2013 | -4.722M |
| March 31, 2013 | -6.779M |
| December 31, 2012 | -7.442M |
| September 30, 2012 | -7.737M |
| June 30, 2012 | -7.954M |
| March 31, 2012 | -6.685M |
| December 31, 2011 | -6.372M |
| September 30, 2011 | -6.531M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.37M
Minimum
Jun 2019
10.27M
Maximum
Dec 2020
2.328M
Average
2.692M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -17.29M |
| Chimerix Inc | -14.59M |
| Karyopharm Therapeutics Inc | -18.58M |
| Axsome Therapeutics Inc | -30.37M |
| Y-mAbs Therapeutics Inc | -8.036M |